“WE SET OUT TO DEVELOP A Dx PLATFORM THAT DOES TESTING BETTER THAN WHAT IS DONE IN THE LABS. IT JUST HAPPENED TO BE A ONE THAT IS PORTABLE”
PBSDx is A Next Generation Diagnostic Platform
PBSDx is equipped with the next generation biological imaging molecules (PBS), advanced AI/Machine Learning algorithms and Optics to complement the core PBS technology
Products Pipeline Based on PBSDX Platform
We are developing a robust portfolio of human and veterinary diagnostic tests internally and collaborate with commercial, academic and government partners
Testing and Prediction for Human Heart health
Heart failure (HF) is the end result of cardiac and non-cardiac abnormalities leading to a complex clinical diagnosis with multiple phenotypes. In 2018, HF was mentioned on 379,800 death certificates (13.4F%). Quick, accurate diagnosis and prompt treatment is essential as each 30 minutes of delay increases the relative risk of 1-year mortality by 7.5% in patients with AMI. Our PBSDx based HF Multiplex Test PBSHeartSafe is cost effective and allow accurate measurements with predictive capability
Testing of Blood Platelets for Bacterial Contamination
Among all transfusable blood products, platelets carry the highest risk for causing transfusion-related sepsis. According to the FDA, microbial contamination was the third highest cause of transfusion-associated fatalities. Our PBSDxTM based automated test (PBSBactiSafe) has better sensitivity and will have the convenience of using at various settings.
Testing of Companion Animals
PBSDx Multiplex Point-of-Solution diagnostic offerings will give veterinarians new choice to deliver comprehensive healthcare for companion animals faster and economically than previously possible.